327 related articles for article (PubMed ID: 11027274)
21. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse.
Kerouz NJ; Hörsch D; Pons S; Kahn CR
J Clin Invest; 1997 Dec; 100(12):3164-72. PubMed ID: 9399964
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
23. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats.
Anai M; Funaki M; Ogihara T; Terasaki J; Inukai K; Katagiri H; Fukushima Y; Yazaki Y; Kikuchi M; Oka Y; Asano T
Diabetes; 1998 Jan; 47(1):13-23. PubMed ID: 9421369
[TBL] [Abstract][Full Text] [Related]
24. A phosphatidylinositol 3-Kinase/p70 ribosomal S6 protein kinase pathway is required for the regulation by insulin of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase gene expression in human muscle cells.
Roques M; Vidal H
J Biol Chem; 1999 Nov; 274(48):34005-10. PubMed ID: 10567366
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.
Ren SY; Bolton E; Mohi MG; Morrione A; Neel BG; Skorski T
Mol Cell Biol; 2005 Sep; 25(18):8001-8. PubMed ID: 16135792
[TBL] [Abstract][Full Text] [Related]
26. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
Ueki K; Yballe CM; Brachmann SM; Vicent D; Watt JM; Kahn CR; Cantley LC
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):419-24. PubMed ID: 11752399
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphorylation of the catalytic subunit p110 of phosphatidylinositol-3 kinase induced by HMG-CoA reductase inhibitor inhibits its kinase activity in L6 myoblasts.
Nakagawa H; Mutoh T; Kumano T; Kuriyama M
FEBS Lett; 2001 Nov; 508(1):53-6. PubMed ID: 11707267
[TBL] [Abstract][Full Text] [Related]
28. Five isoforms of the phosphatidylinositol 3-kinase regulatory subunit exhibit different associations with receptor tyrosine kinases and their tyrosine phosphorylations.
Inukai K; Funaki M; Anai M; Ogihara T; Katagiri H; Fukushima Y; Sakoda H; Onishi Y; Ono H; Fujishiro M; Abe M; Oka Y; Kikuchi M; Asano T
FEBS Lett; 2001 Feb; 490(1-2):32-8. PubMed ID: 11172806
[TBL] [Abstract][Full Text] [Related]
29. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
[TBL] [Abstract][Full Text] [Related]
30. Role of IRS-3 in the insulin signaling of IRS-1-deficient brown adipocytes.
Arribas M; Valverde AM; Benito M
J Biol Chem; 2003 Nov; 278(46):45189-99. PubMed ID: 12944402
[TBL] [Abstract][Full Text] [Related]
31. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
[TBL] [Abstract][Full Text] [Related]
32. Cancer-derived mutations in the regulatory subunit p85alpha of phosphoinositide 3-kinase function through the catalytic subunit p110alpha.
Sun M; Hillmann P; Hofmann BT; Hart JR; Vogt PK
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15547-52. PubMed ID: 20713702
[TBL] [Abstract][Full Text] [Related]
33. Impact of natural IRS-1 mutations on insulin signals: mutations of IRS-1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling.
Yoshimura R; Araki E; Ura S; Todaka M; Tsuruzoe K; Furukawa N; Motoshima H; Yoshizato K; Kaneko K; Matsuda K; Kishikawa H; Shichiri M
Diabetes; 1997 Jun; 46(6):929-36. PubMed ID: 9166661
[TBL] [Abstract][Full Text] [Related]
34. The regulation of class IA PI 3-kinases by inter-subunit interactions.
Backer JM
Curr Top Microbiol Immunol; 2010; 346():87-114. PubMed ID: 20544340
[TBL] [Abstract][Full Text] [Related]
35. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
36. Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice.
Hörsch D; Kahn CR
J Comp Neurol; 1999 Dec; 415(1):105-20. PubMed ID: 10540361
[TBL] [Abstract][Full Text] [Related]
37. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
[TBL] [Abstract][Full Text] [Related]
38. Paraquat-induced oxidative stress represses phosphatidylinositol 3-kinase activities leading to impaired glucose uptake in 3T3-L1 adipocytes.
Shibata M; Hakuno F; Yamanaka D; Okajima H; Fukushima T; Hasegawa T; Ogata T; Toyoshima Y; Chida K; Kimura K; Sakoda H; Takenaka A; Asano T; Takahashi S
J Biol Chem; 2010 Jul; 285(27):20915-25. PubMed ID: 20430890
[TBL] [Abstract][Full Text] [Related]
39. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
[TBL] [Abstract][Full Text] [Related]
40. Targeting of constitutively active phosphoinositide 3-kinase to GLUT4-containing vesicles in 3T3-L1 adipocytes.
Frevert EU; Bjørbaek C; Venable CL; Keller SR; Kahn BB
J Biol Chem; 1998 Sep; 273(39):25480-7. PubMed ID: 9738018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
